Summary We have examined the ability of a series of non-or minimally-immunosuppressive analogues of cyclosporin A to modify cytotoxic drug resistance in vitro. The series includes both cyclosporins derived from naturally-occurring compounds and synthetic cyclosporins. In contrast to our previous findings, we now report that several of these analogues are highly effective modifiers of resistance to adriamycin and vincristine in a multidrug resistant subline of the human small cell lung cancer cell line NCI-H69. Two of the analogues (W8-032 and B3-243) maintain considerable activity in the dose range 1-2pgml-1 whereas little activity remains for cyclosporin A when the dose is reduced to this level. B3-243, Pleiotropic drug resistance in model systems may be partially overcome by the use of additional chemical agents termed 'resistance modifiers'. The prototype agent is the calcium transport blocker, verapamil (Tsuruo et al., 1981 (Tsuruo et al., , 1982 Slater et al., 1982; Twentyman et al., 1986a) . Recently, it has been shown by Slater et al. (1986a, b) that the immunosuppressive drug, cyclosporin A acts as a modifier of resistance to daunorubicin and vincristine (VCR) in Ehrlich ascites carcinoma in vivo and in human acute lymphatic leukaemia in vitro. Our studies of cyclosporin A in a highly multi-drug resistant variant of a human small cell lung cancer cell line confirmed that the agent could considerably reduce the degree of resistance to both adriamycin (ADM) and VCR. Three naturallyoccurring analogues were also studied and a close correlation was seen between the immunosuppressive properties of the analogues and their ability to modify drug resistance. In an attempt to further clarify this relationship, we have now studied an additional series of cyclosporin analogues and the results of these studies are the subject of this paper.
Pleiotropic drug resistance in model systems may be partially overcome by the use of additional chemical agents termed 'resistance modifiers'. The prototype agent is the calcium transport blocker, verapamil (Tsuruo et al., 1981 (Tsuruo et al., , 1982 Slater et al., 1982; Twentyman et al., 1986a) . Recently, it has been shown by Slater et al. (1986a, b) that the immunosuppressive drug, cyclosporin A acts as a modifier of resistance to daunorubicin and vincristine (VCR) in Ehrlich ascites carcinoma in vivo and in human acute lymphatic leukaemia in vitro. Our studies of cyclosporin A in a highly multi-drug resistant variant of a human small cell lung cancer cell line confirmed that the agent could considerably reduce the degree of resistance to both adriamycin (ADM) and VCR. Three naturallyoccurring analogues were also studied and a close correlation was seen between the immunosuppressive properties of the analogues and their ability to modify drug resistance. In an attempt to further clarify this relationship, we have now studied an additional series of cyclosporin analogues and the results of these studies are the subject of this paper.
Materials and methods

Cells and culture conditions
The cells used in this study were of the human small cell lung cancer line NCI-H69 and a highly multi-drug resistant subline (e.g. >100 fold resistance to ADM) derived in this laboratory (Twentyman et al., 1986a) . The parent cells are designated H69/P and the resistant subline H69/LX4. The cells are routinely grown in RPMI 1640 medium (Gibco Biocult) supplemented with 10% foetal calf serum (Seralab Ltd) together with penicillin and streptomycin. The cells grow as free-floating aggregates and the population doubling times of H69/P and H69/LX4 in the absence of drug are 39 (95% CL = 33-47) and 54 (46-64) h respectively. Subline H69/LX4 is routinely maintained in the presence of 0.4pgml-1 ADM but cells were washed free of drug and kept in drug-free medium for 2-3 days before use in experiments. Growing cultures of cells were mechanically disaggregated for experimental use by repeated pipetting. This resulted in a suspension consisting of single cells and small aggregates of up to 10 cells. From this mechanicallydisaggregated suspension an aliquot was taken and formally disaggregated using trypsin and versene (Twentyman et al., 1986b which was actually used for setting up experiments. This procedure was considered necessary as enzymatic reduction of H69 cultures to a single cell suspension results in a prolonged 'lag' in subsequent growth whereas mechanical disaggregation appears to be much less growth inhibitory.
Response assay
To determine the drug response of H69/P and LX4 cells, we used a tetrazolium dye reduction assay (MTT) carried out on 96-well microtitre plates (Falcon Plastics). The assay is based on that originally described by Mosmann (1983) but using DMSO as the solvent (Alley et al., 1986; Carmichael et al., 1987) . We have previously studied a number of variables involved in the optimal use of this assay (Twentyman & Luscombe, 1987) . Evidence that the assay may be validly used to assess the response of human lung cancer cells to cytotoxic drugs has recently been published (Cole, 1986; Carmichael et al., 1987) .
The assay is based on the ability of viable cells to reduce a yellow-coloured soluble tetrazolium salt, [3] [4] 5 dimethylthiazol-2, 5 diphenyl tetrazolium bromide (MTT) to an insoluble, purple-coloured formazan precipitate. After aspiration of most of the medium, the formazan may be dissolved in DMSO and the optical density measured at 550 nm using an ELISA plate reader (Twentyman & Luscombe, 1987 The bulk of the medium was removed from each well using a Pasteur pipette connected to a vacuum line, leaving 10-20 p1 medium per well. To each well was then added 200 p1 DMSO and the plates were agitated on a plate-shaker for 5 min. Optical densities were then read at a wavelength of 540 nm on a 'Titertek Multiskan' ELISA plate reader.
Drugs
Cyclosporin A and 6 analogues were kindly supplied by Sandoz (Basel) Ltd. The structures of those compounds are shown in Figure 1 and their immunosuppressive properties in Table I . The cyclosporins were initially dissolved in absolute ethanol at a concentration of 5mg ml-and then diluted in medium before addition to wells. The final concentration of ethanol in the wells was 0. 1% and control experiments Cyclosporin A showed that this neither affects cell growth or modifies the response to ADM or VCR in our system. In one preliminary experiment, cyclosporins were (mistakenly) added to wells in a final ethanol concentration of 1.0% but again we were able to show that this did not affect cell growth or ADM response. Upon dilution of the alcoholic solutions into medium, a fine precipitation of the cyclosporins was seen to occur. We were unwilling to use agents such as Tween 80 in order to prevent this because of the possibility that such membrane-active agents may themselves modify drugresistance. It was considered that protein-binding of the cyclosporins would enable the drug to be presented to the cells in an acceptable state despite the apparent precipitation.
Cytotoxic drugs adriamycin (ADM, Pharmitalia) and vincristine (VCR, Eli Lilley) were initially dissolved in sterile water and solutions of 500pgml-1 stored either at -20°C (ADM) or +4°C (VCR). Dilutions for use in experiments were prepared immediately before use. MeLeu -MeLeu Z-Ala *-Ala --MeLeu 10 9 
Results
We first of all studied the relationship in the MTT assay between the number of cells plated and the final optical density (OD) 6 days later. A typical set of results is shown in Figure 2 . It may be seen that the relationship is approximately linear for both H69/P and H69/LX4 up to a cell number plated of 104 (OD= 1.8) (H69/P) or 2 x 104 (OD=1.4) (H69/LX4) with both lines passing through the origin. These data enabled us to select the optimal number of cells to plate in subsequent experiments. A typical set of dose-response data obtained using the MTT assay is shown in Figure 3 . For each dose-response curve an ID50 can be read as the drug dose required to reduce to final optical density to 50% of the control value. There is a very close agreement between several of the curves shown in Figure 3 and the corresponding curves which we have previously published using a 'total cell count assay' for fractional optical densities above 0.2-0.3. At higher drug doses, the MTT curves tend to show a plateau not seen when using total cell count as the endpoint. We believe that this plateau represents an artefact of the MTT assay and hence we have used the ID50 to quantitate drug sensitivity using MTT whereas we previously used the ID80. In a preliminary experiment, the effect of each of the cyclosporins to inhibit cell growth and modify ADM sensitivity was studied at the very high dose level of 50 pg ml-1. Three of the cyclosporins (CsA, B3-243 and WO-039) produced essentially total inhibition of cell growth in both H69/P and H69/LX4 at this concentration. Two agents (W8-032 and W4-717) inhibited the growth of H69/P by -70% whereas W8-582 and B3-665 inhibited growth by 44% and 35% respectively. These latter 4 agents all produced rather less growth inhibition in H69/LX4 than in H69/P (in terms of % of final optical density). Where it was possible to assess sensitisation to ADM (for W8-032, W4-717, B3-665 and W8-582) all of the agents were seen to produce considerably more sensitisation in resistant (H69/LX4) than in control (H69/P) cells.
The effects in combination with ADM of the cyclosporins at dose of 5 pg ml-1 were then studied. Results are shown in Table II . It may be seen that the sensitisation ratios ( SR -ID50 in absence of cyclosporin ID50 in presence of cyclosporinn in the parent cells are all 2.1 or less. In the resistant cells, however, very much higher values of SR were obtained with values of 10 or greater being obtained for each agent except B3-665. At 5pgml-1, only B3-243 was itself growth inhibitory (-50% of control). The ID50s for CsA and W8-032 alone were subsequently determined to be >10 pg ml-1. Four of the cyclosporins were then studied at further reduced dose levels in combination with ADM. Results of two independent experiments are shown in Table III Figure 4 . It is seen that, whereas most This was rather variable but averaged -40% at 2pgml-1 and -20% at 1 pg ml -1. The extent was, however, similar in parent and resistant cells and does not, therefore, appear to be directly related to resistance modification. A similar experiment was carried out in which these 4 cyclosporins were combined with VCR. Results are shown in Table IV . It is again seen that W8-032 and B3-243 maintain activity to lower dose levels than does CsA, producing sensitisation ratios of 13.1 and 25.0 respectively at 1 pg ml1 compared with 3.9 for CsA. Two different experiments are shown.
'SR= sensitisation ratio (see Table II ).
Discussion
In our previous study , we found that, in a series of naturally-occurring cyclosporins, there was good agreement between the immunosuppressive properties of these agents and their ability to act as modifiers of multi-drug resistance. Cyclosporins A and G are highly immunosuppressive (von Wartburg & Traber, 1986) and were the most potent resistance modifiers whilst the non-immunosuppressive cyclosporin H had little or no resistance-modifying ability. Each of these analogues has only a single amino acid change compared with CsA (von Wartburg & Traber, 1986) . In further studies of CsA, however, we found that a concentration of 5pgmml1 was Relationship between sensitisation ratio (see Table II 'SR= sensitisation ratio (see Table H ).
required for major reduction of ADM or VCR resistance and most of the effect was lost if the dose were reduced to 2 jug ml-1 This is unfortunate in view of the fact that plasma concentrations of CsA achievable clinically appears to lie in the range of 1-2 pgml1 (Kahan et al., 1983 Figure 4 ). Although the effects of these resistance modifiers are much greater in LX4 cells, there is often a small degree of sensitisation in the parent H69 cells also. This is clearly a fact which must be borne in mind when considering possible increased normal tissue toxicity by drugs such as ADM when combined with cyclosporins. Furthermore, it is clear that these cyclosporins can be growth-inhibitory on their own. A study by Saydjari et al. (1986) has previously found growth inhibition by CsA in a hamster pancreatic carcinoma cell line. In the cells used in the present study, B3-243 was more growth-inhibitory than either CsA or W8-032. For these latter two agents, resistance modification occurs at dose levels which are not in themselves growth-inhibitory. Furthermore, growth-inhibitory effects of B3-243 are similar in H69/P and H69/LX4 cells. It would not therefore appear that there is a direct relationship between the growth inhibition by a given cyclosporin in a cell line and its ability to act as a resistance modifier in that line. Nevertheless, the relative growth-inhibitory properties of different CsA analogues will be an important factor in considering their relative potential merits as resistance modifiers.
The studies described in this paper demonstrate that the immunosuppressive properties and cytotoxic drug resistance modification abilities of cyclosporins can be dissociated. Hence it would seem that the biochemical mechanism of action of cyclosporins in carrying out these two functions must differ. It is not possible to identify on the basis of the results presented in this paper and our previously published data ) the structure/activity requirements for the cyclosporins either in terms of immunosuppression or resistance modification. However, studies of the immunosuppressive activity of a wider range of natural analogues (von Wartburg & Traber, 1986) led to the conclusion that an intact Cg amino acid at position 1 was required. In addition, changes at other positions which resulted in drastic distortion of the ring conformation led to reduction or loss of immunosuppressive activity. Clearly the modification of Cg in position 1 which occurs in B3-243 is incompatible with immunosuppression but perfectly compatible with resistance modification. The compound W8-582 is the only compound in our series which has major distortion of the ring conformation. The limited data for this agent (Table II) 
